Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,277,080 | 1,507,431 | 1,174,052 | 1,246,667 | 1,518,999 |
| Marketable Securities | 469,350 | 369,389 | 342,781 | 271,809 | 264,267 |
| Receivables | 3,687,848 | 3,605,294 | 4,374,643 | 4,397,124 | 3,935,797 |
| Inventories | 2,237,698 | 2,308,805 | 2,398,739 | 2,406,347 | 2,358,521 |
| Other current assets | 174,232 | 252,312 | 285,576 | 973,368 | 549,376 |
| TOTAL | $8,573,201 | $8,896,415 | $9,358,188 | $10,078,210 | $9,417,537 |
| Non-Current Assets | |||||
| PPE Net | 3,945,473 | 3,865,051 | 3,930,272 | 3,987,686 | 4,094,103 |
| Investments And Advances | 1,532,997 | 1,622,342 | 1,478,640 | 1,416,906 | 1,357,758 |
| Intangibles | 17,898,724 | 17,082,446 | 17,404,678 | 17,410,053 | 17,330,147 |
| Other Non-Current Assets | 4,371,996 | 4,282,621 | 4,331,040 | 4,385,855 | 4,522,692 |
| TOTAL | $27,749,190 | $26,852,460 | $27,144,630 | $27,200,500 | $27,304,700 |
| Total Assets | $36,322,390 | $35,748,880 | $36,502,820 | $37,278,700 | $36,722,230 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 29,217 | 1,151,054 | 864,538 | 982,419 | 1,022,344 |
| Accounts payable and accrued liabilities | 1,065,135 | 954,719 | 980,802 | 907,008 | 957,997 |
| Other current liabilities | 3,586,965 | 3,514,261 | 3,732,639 | 3,931,537 | 3,759,492 |
| TOTAL | $6,124,751 | $6,475,598 | $6,392,396 | $6,735,250 | $6,614,574 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,774,839 | 6,855,399 | 7,380,696 | 7,617,976 | 7,532,660 |
| Other Non-Current Liabilities | 5,537,972 | 5,385,641 | 5,569,224 | 5,672,938 | 5,642,283 |
| TOTAL | $13,134,540 | $13,009,160 | $13,755,160 | $14,114,290 | $14,060,900 |
| Total Liabilities | $19,259,290 | $19,484,760 | $20,147,560 | $20,849,540 | $20,675,470 |
| Shareholders' Equity | |||||
| Common Shares | 317,502 | 322,637 | 315,977 | 318,559 | 317,561 |
| Retained earnings | 12,191,250 | 12,194,560 | 11,708,010 | 11,972,150 | 11,820,540 |
| Other shareholders' equity | 934,292 | 33,521 | 684,144 | 462,729 | 250,127 |
| TOTAL | $17,063,110 | $16,264,120 | $16,355,260 | $16,429,170 | $16,046,760 |
| Total Liabilities And Equity | $36,322,400 | $35,748,880 | $36,502,820 | $37,278,710 | $36,722,230 |